Industry News

L’Oréal Inks Tri-Party Deal for Sustainable Beauty Ingredients

The accord with Evonik and Abolis includes a minority stake in the biotech company, which has specialized expertise in microorganisms.

Author Image

By: Christine Esposito

Editor-in-Chief

L’Oréal has signed a tri-party agreement with biotech company Abolis and Evonik that will enable the end-to-end discovery, development and manufacturing of innovative and sustainable ingredients for beauty products. As part of the accord, L’Oréal and Evonik have taken respective minority investments in the French biotech start-up. Abolis, based in Genopole, has unique expertise in tailor-made industrial solutions based on microorganisms for a wide range of industries including...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters